Covered recipient · General Payments record
NATHAN C KING
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$5,247.35
- Reported across 238 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $655.42 | 27 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $212.75 | 9 |
| Amgen Inc. | $86.88 | 4 |
| Lilly USA, LLC | $77.61 | 3 |
| CATALYST PHARMACEUTICALS, INC. | $63.96 | 1 |
| Novo Nordisk AS | $60.32 | 3 |
| PFIZER INC. | $56.67 | 3 |
| Philips Electronics North America Corporation | $49.67 | 2 |
| Acerta Pharma LLC | $47.56 | 2 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (27)
Sorted by paying entity, then date · as published by CMS
Program year 2024 201820192020202120222023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $30.84 | 01/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078378 | CMS |
| ABBVIE INC. | $5.56 | 01/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078380 | CMS |
| ABBVIE INC. | $32.90 | 04/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078382 | CMS |
| ABBVIE INC. | $22.21 | 04/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078384 | CMS |
| ABBVIE INC. | $32.07 | 06/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078386 | CMS |
| ABBVIE INC. | $10.44 | 06/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078388 | CMS |
| ABBVIE INC. | $29.08 | 07/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078390 | CMS |
| ABBVIE INC. | $17.41 | 09/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078392 | CMS |
| ABBVIE INC. | $32.24 | 11/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1104078394 | CMS |
| Amgen Inc. | $21.84 | 01/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115815799 | CMS |
| Amgen Inc. | $23.04 | 08/13/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115815781 | CMS |
| Amgen Inc. | $17.01 | 11/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117599008 | CMS |
| Amgen Inc. | $24.99 | 12/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1115815790 | CMS |
| AstraZeneca Pharmaceuticals LP | $22.95 | 02/28/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105566348 | CMS |
| AstraZeneca Pharmaceuticals LP | $24.61 | 10/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105550632 | CMS |
| CATALYST PHARMACEUTICALS, INC. | $63.96 | 01/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144444082 | CMS |
| Lilly USA, LLC | $27.41 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238160 | CMS |
| Lilly USA, LLC | $23.40 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238156 | CMS |
| Lilly USA, LLC | $26.80 | 08/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135238152 | CMS |
| Novo Nordisk Inc | $22.88 | 02/21/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097619792 | CMS |
| Novo Nordisk Inc | $18.36 | 03/26/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097240852 | CMS |
| Novo Nordisk Inc | $19.08 | 10/23/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096863221 | CMS |
| PFIZER INC. | $19.38 | 03/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131325053 | CMS |
| PFIZER INC. | $15.00 | 04/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131399880 | CMS |
| PFIZER INC. | $22.29 | 06/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131999393 | CMS |
| Philips North America LLC | $26.13 | 03/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146892167 | CMS |
| Philips North America LLC | $23.54 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1146892165 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.